logo image
search icon
Per-Encounter Medical Market

Per-Encounter Medical Market Size, Share & Trends Analysis Report By Product Type (Consumables, Devices, Software, Services, Others), By Application (Cardiology, Orthopedics, Obstetrics/Gynecology, Ophthalmology, Gastroenterology, Others), By End-User, By Distribution Channel, By Region, And By Segment Forecasts, 2023-2031.

Report ID : 2253 | Published : 2023-12-04 | Pages: 179 | Format: PDF/EXCEL

Per-Encounter Medical Market Size is valued at USD 107.21 Bn in 2022 and is predicted to reach USD 377.93 Bn by the year 2031 at a 15.20% CAGR during the forecast period for 2023-2031.

Per-Encounter Medical Market

Per-encounter medical describes a billing model in which a healthcare practitioner charges a set amount for each patient encounter. This means the patient will always be charged the same amount for each appointment, no matter how long or complicated. This strategy stands in contrast to other payment schemes like capitation and fee-for-service. Under the fee-for-service model, medical professionals charge patients for each treatment they receive. Over a specific period, providers receive a fixed compensation per patient, independent of the number of visits or services provided. Medical billing based on each encounter is common in urgent care centres, walk-in clinics, and treatments requiring regular time and resources.

Furthermore, rising healthcare expenses and an emphasis on value-based care will likely propel the global per-encounter medical industry to steady growth. Payers and providers alike are looking toward pay-for-performance and episode-based payment models to rein in soaring healthcare costs. As a result, more and more people will start paying for each encounter.

However, the market growth is hampered by the high-cost criteria for the safety and health of per-encounter medical and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity per-encounter medical, prices for per-encounter equipment such as syringes, surgical kits, and IV therapy systems are falling due to price pressure from payers, cost-containment initiatives, and unified healthcare systems. Medical device businesses must seek out low-cost manufacturing, regional production, and materials substitution to maintain profit margins. Industry profitability is affected, while market growth is moderated to some extent due to the capacity to charge lower per-unit rates. 

Competitive Landscape

Some Major Key Players In The Per-Encounter Medical Market:

  • Abbott
  • Cardinal Health
  • Johnson & Johnson
  • Medtronic
  • 3M
  • Steris
  • Catalent Inc.,
  • Smiths Medical Inc.,
  • Schott,
  • Nipro Corporation,
  • Terumo Corporation,
  • Gerresheimer AG,
  • Becton, Dickinson and Company,
  • Braun Melsungen AG,
  • AngioDynamics Inc.,
  • Teleflex Incorporated,
  • Argon Medical Devices, Inc.,
  • ICU Medical, Inc.,
  • Medical Components, Inc.,
  • Vygon (UK) Ltd
  • Others

Market Segmentation:

The per-encounter medical market is segmented based on product type, application, end-user, and distribution channel. The product type segment is segmented into consumables, devices, software, services, and others. The application segment comprises cardiology, orthopaedics, obstetrics/gynaecology, ophthalmology, gastroenterology, and others. The end-use segment includes hospitals, clinics, diagnostic centres, and others. The distribution channel segment is segmented into direct tender, retail sales, and online sales. 

Based On The Application, The Gastroenterology Per-Encounter Medical Market Segment Is A Major Contributor To The Per-Encounter Medical Market. 

The gastroenterology per-encounter medical market is expected to lead with a major global market share in 2022. A gastroenterologist checks the digestive system for problems, including the smooth passage of food and other substances. Additionally, gastroenterologists are responsible for ensuring normal nutritional digestion and absorption and correctly eliminating waste from the body.

Retail Sales Segment To Witness Growth At A Rapid Rate.

The retail sales industry makes up the bulk of per-encounter medical usage because when retail sales rise, the economy grows well; however, when they fall, it means the reverse. Stock prices tend to rise and benefit shareholders when retail sales increase, especially in countries like the US, Germany, the UK, China, and India.

In The Region, The North American Per-Encounter Medical Market Holds A Significant Revenue Share.

The North American per-encounter medical market is expected to register the maximum revenue share in the near future. This can be attributed to the area's high rate of chronic diseases, well-developed healthcare system, and welcoming reimbursement rules. In addition, Asia Pacific is estimated to grow rapidly in the global per-encounter medical market due to the growing number of patients, increasing disposable incomes, and better healthcare facilities.

Recent Developments:

  • In August 2023, Abbott released the "Vertigo Coach" app, a digital health solution that provides 24/7 access to resources for those with vertigo, allowing them to manage their illness holistically. People with vertigo will find it a helpful companion, offering advice on healthy habits and exercise to help them manage their illness.
  • In April 2021, Cardinal Health unveiled a novel platform aimed at enhancing medication adherence. The software, Outcomes, comprises medication therapy management, digital patient engagement, and pharmacy telehealth technologies..

Per-Encounter Medical Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 107.21 Bn

Revenue Forecast In 2031

USD 377.93 Bn

Growth Rate CAGR

CAGR of 15.20 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By Application, By End-User, By Distribution Channel

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea

Competitive Landscape

Abbott, Cardinal Health, Johnson & Johnson, Medtronic, 3M, Steris, Catalent Inc., Smiths Medical Inc., Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., Vygon (UK) Ltd, Others

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Per-Encounter Medical Market Snapshot

Chapter 4. Global Per-Encounter Medical Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis

5.1. By Product Type, & Market Share, 2020 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product Type:

5.2.1. Consumables

5.2.2. Devices

5.2.3. Software

5.2.4. Services

5.2.5. Others

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2020 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:

6.2.1. Cardiology

6.2.2. Orthopedics

6.2.3. Obstetrics/Gynecology

6.2.4. Ophthalmology

6.2.5. Gastroenterology

6.2.6. Others

Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis

7.1. By Distribution Channel & Market Share, 2020 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Distribution Channel:

7.2.1. Direct Tender

7.2.2. Retail Sales

7.2.3. Online Sale

Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis

8.1. By End User & Market Share, 2020 & 2031

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:

8.2.1. Hospitals

8.2.2. Clinics

8.2.3. Diagnostic Centers

8.2.4. Others

Chapter 9. Per-Encounter Medical Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By Product Type, 2019-2031

9.1.2. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031

9.1.3. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031

9.1.4. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031

9.1.5. North America Per-Encounter Medical Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

9.2. Europe

9.2.1. Europe Per-Encounter Medical Market revenue (US$ Million) By Product Type, 2019-2031

9.2.2. Europe Per-Encounter Medical Market revenue (US$ Million) By Application, 2019-2031

9.2.3. Europe Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, 2019-2031

9.2.4. Europe Per-Encounter Medical Market revenue (US$ Million) By End User, 2019-2031

9.2.5. Europe Per-Encounter Medical Market revenue (US$ Million) by country, 2019-2031

9.3. Asia Pacific

9.3.1. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By Product Type, 2019-2031

9.3.2. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By Application, 2019-2031

9.3.3. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, 2019-2031

9.3.4. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) By End User, 2019-2031

9.3.5. Asia Pacific Per-Encounter Medical Market revenue (US$ Million) by country, 2019-2031

9.4. Latin America

9.4.1. Latin America Per-Encounter Medical Market revenue (US$ Million) By Product Type, (US$ Million) 2019-2031

9.4.2. Latin America Per-Encounter Medical Market revenue (US$ Million) By Application, (US$ Million) 2019-2031

9.4.3. Latin America Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031

9.4.4. Latin America Per-Encounter Medical Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

9.4.5. Latin America Per-Encounter Medical Market revenue (US$ Million) by country, 2019-2031

9.5. Middle East & Africa

9.5.1. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By Product Type, (US$ Million) 2019-2031

9.5.2. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By Application, (US$ Million) 2019-2031

9.5.3. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031

9.5.4. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

9.5.5. Middle East & Africa Per-Encounter Medical Market revenue (US$ Million) by country, 2019-2031

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Abbott

10.2.2. BD

10.2.3. Cardinal Health

10.2.4. Johnson & Johnson

10.2.5. Medtronic

10.2.6. 3M

10.2.7. Steris

10.2.8. Teleflex 

Segmentation of Per-Encounter Medical Market-

Per-Encounter Medical Market By Product Type-

  • Consumables
  • Devices
  • Software
  • Services
  • Others

Per-Encounter Medical Market Seg

Per-Encounter Medical Market By Application-

  • Cardiology
  • Orthopedics
  • Obstetrics/Gynecology
  • Ophthalmology
  • Gastroenterology
  • Others

Per-Encounter Medical Market By End-User-

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Per-Encounter Medical Market By Distribution Channel-

  • Direct Tender
  • Retail Sales
  • Online Sales

Per-Encounter Medical Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Per-Encounter Medical Market?

Per-Encounter Medical Market expected to grow at a 15.20% CAGR during the forecast period for 2023-2031.

AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., Vygon (UK) Ltd, Others

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach